APA (7th ed.) Citation

RL, S., M, H., MJ, C., EL, S., S, S., MJ, H., . . . SS, K. (2023). AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells. Cancer immunology research, 11(9), 1222. https://doi.org/10.1158/2326-6066.CIR-22-0254

Chicago Style (17th ed.) Citation

RL, Sakemura, et al. "AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells." Cancer Immunology Research 11, no. 9 (2023): 1222. https://doi.org/10.1158/2326-6066.CIR-22-0254.

MLA (9th ed.) Citation

RL, Sakemura, et al. "AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells." Cancer Immunology Research, vol. 11, no. 9, 2023, p. 1222, https://doi.org/10.1158/2326-6066.CIR-22-0254.